XML 28 R12.htm IDEA: XBRL DOCUMENT v3.25.0.1
Inventory
 12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
Inventory Inventory
At December 31, 2024 and 2023, the Company’s inventory primarily related to ORLADEYO. Inventory also included peramivir, which is primarily manufactured for the Company’s partners.
The Company’s inventories consisted of the following (in thousands):
December 31,
20242023
Raw materials$10,006 $6,449 
Work-in-process16,152 17,591 
Finished goods7,765 6,242 
Total inventory33,923 30,282 
Reserves(2,649)(1,599)
Total inventory, net$31,274 $28,683